(Q39678142)

English

Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA).

scientific article published on January 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA). (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Martin BJ

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Finlay JA

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sterling K

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ward M

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Lifsey D

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Mercante D

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jainto JM

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Martin L

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Rayford W

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

132-137

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen era: implications for screening a high-risk group for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Comparative evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Characterization of the human kallikrein locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

21 January 2018

Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

7 January 2021

based on heuristic

inferred from DOI database lookup

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

7 January 2021

based on heuristic

inferred from DOI database lookup

Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

7 January 2021

based on heuristic

inferred from DOI database lookup

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500706

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.PCAN.4500706

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39678142&oldid=2203080685"